REAL HEALTH SUPPLEMENTS LIMITED

Company Registration Number:
10597931 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2022

Period of accounts

Start date: 01 January 2022

End date: 31 December 2022

REAL HEALTH SUPPLEMENTS LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2022

Balance sheet
Notes

REAL HEALTH SUPPLEMENTS LIMITED

Balance sheet

As at 31 December 2022


Notes

2022

2021


£

£
Fixed assets
Tangible assets: 3 753,479 71,892
Total fixed assets: 753,479 71,892
Current assets
Debtors: 4 254,843 0
Cash at bank and in hand: 685,443 939,542
Total current assets: 940,286 939,542
Creditors: amounts falling due within one year: 5 (606,413) (681,239)
Net current assets (liabilities): 333,873 258,303
Total assets less current liabilities: 1,087,352 330,195
Provision for liabilities: (7,357) (7,357)
Total net assets (liabilities): 1,079,995 322,838
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 1,079,994 322,837
Shareholders funds: 1,079,995 322,838

The notes form part of these financial statements

REAL HEALTH SUPPLEMENTS LIMITED

Balance sheet statements

For the year ending 31 December 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 13 October 2023
and signed on behalf of the board by:

Name: MR CHRIS BOYLE
Status: Director

The notes form part of these financial statements

REAL HEALTH SUPPLEMENTS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

REAL HEALTH SUPPLEMENTS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

2. Employees

2022 2021
Average number of employees during the period 13 7

REAL HEALTH SUPPLEMENTS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

3. Tangible Assets

Total
Cost £
At 01 January 2022 217,254
Additions 716,717
At 31 December 2022 933,971
Depreciation
At 01 January 2022 145,362
Charge for year 35,130
At 31 December 2022 180,492
Net book value
At 31 December 2022 753,479
At 31 December 2021 71,892

REAL HEALTH SUPPLEMENTS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

4. Debtors

2022 2021
££
Debtors due after more than one year: 0 0

REAL HEALTH SUPPLEMENTS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

5. Creditors: amounts falling due within one year note

CREDITORS - £606,413